Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STEP: Tibolone vs Raloxifene in Osteopenic Postmenopausal Women
NCT00431431Phase 4Completed
- Sponsor
- Organon & Co.
- Start
- Jul 2000
- Primary completion
- Feb 2005
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
Phase 4, randomised, double-blind trial of tibolone in osteopenia (2 arms), sponsored by Organon & Co. Primary endpoint: Bone Mineral Density of the Lumbar Vertebrae L1-L4 at 104 weeks. Started Jul 2000; status: completed.
02
Drugs
tibolone
03
Conditions
osteopenia
Beyond the preview
Go deeper on NCT00431431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00431431.